ZBIO - CIK 0001953926
Zenas BioPharma, Inc. (ZBIO) reported net income of -$377.74M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$377.74M | -140.6% |
| FY 2024 | -$156.99M | -322.9% |
| FY 2023 | -$37.12M | - |
Zenas BioPharma, Inc. (ZBIO) reported net income of -$377.74M for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.